BazaarBaazi

Stock · ABBOTINDIA · Healthcare

ABBOTINDIA share price target 2026

Support, resistance, the F&O structure and the BazaarBaazi Crack Score for Abbott India Limited, refreshed every end-of-day run. A systematic, data-only read on Abbott India Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.

The verdict

BazaarBaazi reads ABBOTINDIA as constructive with a Crack Score of 67/100 as of 25 Jul 2026.
Crack Score
67/ 100
Constructive

BazaarBaaziSource & method

The scanner's readScanned · scanned 24 Jul 2026

Where ABBOTINDIA stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.

Scanned87 /100 setup score

Scanned and scored this run, but the evidence is incomplete or conflicted. The engine fails closed to NO_TRADE.

Technical axis

90/100

Fundamental axis

83/100

Money flow

91/100

Result pulse · Q4 FY26

58/100

Technical evidence

money-flow score 91.2/100

Chaikin money flow +0.378 (accumulation)

up/down volume 1.44x (buyers dominant)

net +7 accumulation days (25d)

relative strength rising vs NIFTY

RS slope +13.9% (3m)

outperforming and above 50DMA

Fundamental evidence

cheaper than sector (0.78x median)

Red flags

above 200DMA (not a confirmed short-side trend)

strong accumulation tape

Relative valuation

P/E (TTM)

38.4

P/E vs sector

+0.8%

Sector percentile

32

PEG

5.05

Scanner levels from the deterministic engine run of 2026-07-24, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.

Open the full 500-name Setup Scan.

Price target: support and resistanceComputed 25 Jul 2026

Support and resistance for ABBOTINDIA are read inside the latest show; no spot was printed in the most recent editorial note.

Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.

These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the ABBOTINDIA chart, refreshed every end-of-day run.

The Crack Score, and how it is built67 / 100 · Constructive

The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for ABBOTINDIA, so the figure is a transparent signal rather than a vibe.

Editorial stanceLatest signed stance is bullish.+18
History consistency1 of the last 6 published verdicts held the same stance.-11
Structure qualityNo clean spot was printed in the latest note; levels are read inside the show.0
FreshnessThe desk last reviewed 4 days ago.+4
Conviction horizonThe latest read is framed on a swing horizon.+6

Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.

The F&O viewHorizon · swing

How the futures and options structure on ABBOTINDIA reads right now.

Editorial directionBullish
Horizonswing

The editorial price read on ABBOTINDIA is bullish. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on ABBOTINDIA can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.

Why it movedLatest editorial line

The most recent BazaarBaazi read on what is driving ABBOTINDIA.

Systematic read: a disclosed, data-only model on real 1-year price structure.

Read in Systematic Read on 21 Jul 2026. Why ABBOTINDIA moved, the living explainer, tracks every move on one URL.

Latest filed resultsQ4 FY26

Abbott India Limited's most recent quarter, parsed straight from the official BSE filing. Every figure links back to its primary source.

Q4 FY26 · ended 31 Mar 2026Standalone, audited · filed with BSE on 11 May 2026

Result Pulse

58 / 100

Revenue

Rs 1,710 cr

Net profit

Rs 395 cr

EPS (quarter)

Rs 185.85
GrowthYoYQoQ
Revenue+6.5%-0.8%
Net profit+7.6%+5.0%
Net margin+23.1%
What BazaarBaazi readsSteady
SourceOfficial BSE filing (XBRL)

Figures are the Q4 FY26 result for Abbott India Limited, parsed straight from the official BSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.

See every Q4 result the desk has read.

Earnings history, every filed quarter31 quarters on record

Abbott India Limited's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Jun 2018. These are quarterly facts, not TTM valuation inputs.

ABBOTINDIA official result trail

31 quarters

Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.

QuarterRevenueEPSPAT YoYPulseSource
Q4 FY26ended 31 Mar 2026 / Standalone, auditedRs 1,710 crRs 185.85+7.6%58/100Filing
Q3 FY26ended 31 Dec 2025 / Standalone, auditedRs 1,724 crRs 176.92+4.2%58/100Filing
Q2 FY26ended 30 Sep 2025 / Standalone, auditedRs 1,757 crRs 195.42+15.8%73/100Filing
Q4 FY25ended 31 Mar 2025 / Standalone, auditedRs 1,605 crRs 172.72+27.9%95/100Filing
Q3 FY25ended 31 Dec 2024 / Standalone, auditedRs 1,614 crRs 169.78n/a58/100Filing
Q2 FY25ended 30 Sep 2024 / Standalone, auditedRs 1,633 crRs 168.76n/a58/100Filing
Q1 FY25ended 30 Jun 2024 / Standalone, auditedRs 1,558 crRs 154.36n/a58/100Filing
Q4 FY24ended 31 Mar 2024 / Standalone, auditedRs 1,439 crRs 565.28n/a58/100Filing
Q3 FY24ended 31 Dec 2023 / Standalone, auditedRs 1,437 crRs 146.34n/an/aFiling
Q2 FY24ended 30 Sep 2023 / Standalone, auditedRs 1,494 crRs 147.27n/an/aFiling
Q1 FY24ended 30 Jun 2023 / Standalone, auditedRs 1,479 crRs 136.58n/an/aFiling
Q4 FY23ended 31 Mar 2023 / Standalone, auditedRs 1,343 crRs 108.90n/an/aFiling
Q3 FY23ended 31 Dec 2022 / Standalone, auditedRs 1,326 crRs 116.16n/an/aFiling
Q2 FY23ended 30 Sep 2022 / Standalone, auditedRs 1,379 crRs 124.95n/an/aFiling
Q1 FY23ended 30 Jun 2022 / Standalone, auditedRs 1,304 crRs 96.77n/an/aFiling
Q4 FY22ended 31 Mar 2022 / Standalone, auditedRs 1,255 crRs 99.49n/an/aFiling
Q3 FY22ended 31 Dec 2021 / Standalone, auditedRs 1,224 crRs 93.74n/an/aFiling
Q2 FY22ended 30 Sep 2021 / Standalone, auditedRs 1,222 crRs 90.51n/an/aFiling
Q1 FY22ended 30 Jun 2021 / Standalone, auditedRs 1,218 crRs 92.12n/an/aFiling
Q4 FY21ended 31 Mar 2021 / Standalone, auditedRs 1,096 crRs 71.75n/an/aFiling
Q3 FY21ended 31 Dec 2020 / Standalone, auditedRs 1,095 crRs 83.36n/an/aFiling
Q2 FY21ended 30 Sep 2020 / Standalone, auditedRs 1,055 crRs 85.05n/an/aFiling
Q1 FY21ended 30 Jun 2020 / Standalone, auditedRs 1,064 crRs 84.87n/an/aFiling
Q4 FY20ended 31 Mar 2020 / Standalone, auditedRs 961 crRs 52.22n/an/aFiling
Q3 FY20ended 31 Dec 2019 / Standalone, auditedRs 1,078 crRs 87.85n/an/aFiling
Q2 FY20ended 30 Sep 2019 / Standalone, auditedRs 1,055 crRs 83.92n/an/aFiling
Q1 FY20ended 30 Jun 2019 / Standalone, auditedRs 999 crRs 55.03n/an/aFiling
Q4 FY19ended 31 Mar 2019 / Standalone, auditedRs 906 crRs 53.28n/an/aFiling
Q3 FY19ended 31 Dec 2018 / Standalone, auditedRs 948 crRs 55.08n/an/aFiling
Q2 FY19ended 30 Sep 2018 / Standalone, auditedRs 980 crRs 64.79n/an/aFiling
Q1 FY19ended 30 Jun 2018 / Standalone, auditedRs 845 crRs 38.78n/an/aFiling

Open the covered-name earnings calendar.

The official financialsFiled to 31 Mar 2026

Abbott India Limited's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.

Trailing twelve months, on filed quarters

Revenue (TTM)

6,929 cr

Net profit (TTM)

1,552 cr

EBIT (TTM)

2,104 cr

Profit before tax (TTM)

2,079 cr

Net margin (TTM)

22.4%

Finance costs (TTM)

25.0 cr

Balance sheet, as filed 2026-03-31

Total assets

6,502 cr

Shareholder equity

4,774 cr

Total borrowings

0.0 cr

Cash and equivalents

442 cr

Inventory

947 cr

Trade receivables

362 cr

The cash engine, latest filed year

Operating cash flow

1,319 cr

Capex

40.9 cr

Free cash flow

1,278 cr

Investing flow

371 cr

Financing flow

1,066 cr

Annual trail, filed year over filed year

YearRevenueNet profitEquityBorrowingsCFO
FY266,929 cr1,552 cr4,774 cr0.0 cr1,319 cr
FY256,409 cr1,414 cr4,233 cr0.0 cr1,012 cr
FY245,849 cr1,201 cr3,699 cr0.0 cr1,213 cr
FY235,349 cr949 cr3,189 cr0.0 cr893 cr
FY224,919 cr799 cr2,820 cr0.0 cr948 cr
FY214,310 cr691 cr2,602 cr0.0 crn/a

Every figure is parsed from Abbott India Limited's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.

Management on record1 earnings call

Every ABBOTINDIA earnings call BazaarBaazi has indexed, latest 30 Sep 2022. Read management in its own words, straight from the filed transcript.

Abbott India Limited earnings calls on record

1 call since 30 Sep 2022

30 Sep 2022Earnings callTranscript PDF

Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.

What changed1 disclosure

Every recent official filing from Abbott India Limited, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.

Abbott India Limited's most recent official filing is a Earnings dated 31 Mar 2026.

Event Heat

61 / 100
31 Mar 2026
EarningsWatch

Abbott India Limited Q4 FY26 earnings result: steady

Filing
Event Heat61 / 100 · Tilting up

Event Heat is a dated net read of Abbott India Limited's last 180 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.

See what changed across the whole market.

Key fundamentalsEditorial reference

The anchor data BazaarBaazi references when reading the ABBOTINDIA chart. Not a substitute for a registered research note.

TickerABBOTINDIA
Full nameAbbott India Limited
SectorHealthcare
Index classMID CAP
ISININE358A01014
Market-cap band~61,200 cr (indicative)
Last referenced levelInside latest show
Last session moveNot referenced this cycle
Editorial line inSystematic Read on 21 Jul 2026
Aliases trackedABBOTINDIA

Reference chartLevels in show

The daily frame the desk reads on ABBOTINDIA.

Chart frame not yet rendered for ABBOTINDIA. The desk references levels inline inside each show.
Structural levels are read inside the latest show.

FAQ11 reader questions · AEO-eligible

The line on ABBOTINDIA, distilled and schema-marked for AI Overview, Perplexity, and reader search.

What is the ABBOTINDIA share price target for 2026?

BazaarBaazi does not publish a SEBI-registered price target on ABBOTINDIA. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.

What is BazaarBaazi's Crack Score for ABBOTINDIA?

The BazaarBaazi Crack Score for ABBOTINDIA is 67 out of 100 as of 25 Jul 2026, a constructive reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.

What is the F&O view on ABBOTINDIA?

Strike-level option inventory for ABBOTINDIA is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.

What sector is ABBOTINDIA in and which peers does BazaarBaazi track?

ABBOTINDIA sits in Healthcare (mid cap), indicative market cap ~61,200 cr (indicative), ISIN INE358A01014. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on Abbott India Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.

How often is the ABBOTINDIA view updated?

This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on ABBOTINDIA is bullish, published in Systematic Read on 21 Jul 2026.

Is ABBOTINDIA a qualifying setup on the BazaarBaazi scanner right now?

On the 2026-07-24 run of the 500-name BazaarBaazi setup scanner, Abbott India Limited sits in the Scanned tier with a setup score of 87/100 (technical 90, fundamental 83). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.

Where can I read Abbott India Limited's earnings call transcripts?

BazaarBaazi indexes 1 ABBOTINDIA earnings call going back to 2022-09-30, latest 2022-09-30. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.

What was Abbott India Limited's Q4 FY26 net profit?

Abbott India Limited reported a net profit of Rs 395 cr for Q4 FY26 (the quarter ended 31 March 2026). That is +7.6% year on year. The figure is from the company's official NSE filing.

What was Abbott India Limited's Q4 FY26 revenue?

Abbott India Limited reported revenue of Rs 1,710 cr for Q4 FY26. That is +6.5% year on year. The figure is from the company's official NSE filing.

How does BazaarBaazi rate Abbott India Limited's Q4 FY26 result?

BazaarBaazi gives Abbott India Limited's Q4 FY26 result a Result Pulse of 58 out of 100, with a verdict of Steady. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.

What has Abbott India Ltd announced recently?

The most recent official filing on record for Abbott India Ltd is an earnings dated 31 Mar 2026. It is the company's own earnings disclosure to the exchange, and it links to that filing on the BazaarBaazi stock page rather than to any third-party summary.

Related stock views

The names BazaarBaazi reads alongside ABBOTINDIA, each a living view refreshed every end-of-day run.

All stock viewsAbout BazaarBaazi →